Burzynski Research Institute Inc (BZYR)

Healthcare | Biotechnology
Latest reporting period: 2025-11-30

Latest Quarter

2025-11-30

Revenue

$0.0

Net Income

-$329K

Operating Margin

N/A

Free Cash Flow

-$389K

Debt / Assets

5,015.8%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Burzynski Research Institute Inc (BZYR).
Income Statement (Quarterly) 2025-11-30 2025-08-31 2025-05-31 2025-02-28
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 68,062 78,750 61,179 51,351
Operating Expenses 328,862 333,867 331,451 292,838
Operating Income -328,862 -333,867 -331,451 1,093,407
Interest Expense 0 0 0 0
Income Before Tax -328,862 -333,867 -331,451 -292,798
Income Tax Expense 0 0 0 371,332
Net Income -328,862 -333,867 -331,451 -292,798
Per Share
EPS 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00 0.00